drugset

drugset / Trial / NCT00599521

Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

NCT00599521 ↗

Phase 3 Completed 1067 enrolled Galderma R&D

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether Adapalene, 0.1% is safe and effective in the treatment of Acne Vulgaris.

Timeline

Start: 2007-11
Primary completion: 2008-11
Completion: 2008-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Adapalene	Other / unclassified	0.1 %	Topical

Indications